{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:32:27Z","timestamp":1787927547054,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpet.2026.104974","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:07:08Z","timestamp":1782230828000},"page":"104974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel NAD(P)H:quinone oxidoreductase 1-responsive vascular endothelial growth factor-targeted antibody-drug conjugate induces dual apoptosis and ferroptosis in glioblastoma"],"prefix":"10.1016","volume":"393","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/j.jpet.2026.104974_bib2","first-page":"2613","article-title":"Survival analysis of glioblastoma multiforme","volume":"19","author":"Witthayanuwat","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"issue":"16","key":"10.1016\/j.jpet.2026.104974_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202310318","article-title":"Azobenzene-based linker strategy for selective activation of antibody-drug conjugates","volume":"63","author":"Xiao","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"issue":"9","key":"10.1016\/j.jpet.2026.104974_bib4","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.7150\/thno.71763","article-title":"PTRF\/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"issue":"22","key":"10.1016\/j.jpet.2026.104974_bib5","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1016\/j.biomaterials.2010.03.062","article-title":"Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment","volume":"31","author":"Kievit","year":"2010","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.jpet.2026.104974_bib6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"6398","key":"10.1016\/j.jpet.2026.104974_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/359845a0","article-title":"Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo","volume":"359","author":"Plate","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jpet.2026.104974_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104974_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","article-title":"International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis","volume":"20","author":"Chen","year":"2024","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.jpet.2026.104974_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","article-title":"Cancer therapy with antibodies","volume":"24","author":"Paul","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.jpet.2026.104974_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody-drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-20840-x","article-title":"Anti-VEGF neutralizing antibody delays osteomucosal healing by reducing collagen formation in mice","volume":"15","author":"Bae","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jpet.2026.104974_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104241","article-title":"Antibody-drug conjugates: prospects for the next generation","volume":"29","author":"Grairi","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jpet.2026.104974_bib14","series-title":"Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications","first-page":"117","article-title":"Linker technology and impact of linker design on ADC properties","author":"Goldmacher","year":"2013"},{"issue":"4","key":"10.1016\/j.jpet.2026.104974_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/15569527.2024.2408677","article-title":"Ocular toxicities of FDA-approved antibody drug conjugates","volume":"43","author":"Vetsa","year":"2024","journal-title":"Cutan Ocul Toxicol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104974_bib16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00280-017-3451-1","article-title":"Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study","volume":"80","author":"van den Bent","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104974_bib17","first-page":"965","article-title":"Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma","volume":"19","author":"Reardon","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/neuonc\/noy091","article-title":"Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial","volume":"21","author":"Lassman","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jpet.2026.104974_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jpet.2026.104974_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101578","article-title":"C\/EBP\u03b2 mediates NQO1 and GSTP1 anti-oxidative reductases expression in glioblastoma, promoting brain tumor proliferation","volume":"34","author":"Lei","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.jpet.2026.104974_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100977","article-title":"Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis","volume":"70","author":"Yu","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"8","key":"10.1016\/j.jpet.2026.104974_bib22","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41416-018-0278-4","article-title":"Phase 1 study of ARQ 761, a \u03b2-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis","volume":"119","author":"Gerber","year":"2018","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2026.104974_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00689804","article-title":"NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues","volume":"12","author":"Belinsky","year":"1993","journal-title":"Cancer Metastasis Rev"},{"issue":"16","key":"10.1016\/j.jpet.2026.104974_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202410861","article-title":"NQO1-responsive prodrug for in cellulo release of cytochalasin B as cancer cell-targeted migrastatic","volume":"22","author":"Kagho","year":"2026","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.jpet.2026.104974_bib25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/anie.201813032","article-title":"Chemiluminescent probe for the in vitro and in vivo imaging of cancers over-expressing NQO1","volume":"58","author":"Son","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"10.1016\/j.jpet.2026.104974_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4155\/fmc-2021-0289","article-title":"Research advances in NQO1-responsive prodrugs and nanocarriers for cancer treatment","volume":"14","author":"Yang","year":"2022","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jpet.2026.104974_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117657","article-title":"AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy","volume":"102","author":"Li","year":"2024","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.jpet.2026.104974_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00335-025-10115-1","article-title":"New mouse model for inducible hACE2 expression enables to dissect SARS-CoV-2 pathology beyond the respiratory system","volume":"36","author":"Gambini","year":"2025","journal-title":"Mamm Genome"},{"issue":"16","key":"10.1016\/j.jpet.2026.104974_bib29","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cbic.201800269","article-title":"Trimethyl lock: a multifunctional molecular tool for drug delivery, cellular imaging, and stimuli-responsive materials","volume":"19","author":"Okoh","year":"2018","journal-title":"Chembiochem"},{"issue":"8","key":"10.1016\/j.jpet.2026.104974_bib30","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1039\/c2sc20536j","article-title":"Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology","volume":"3","author":"Levine","year":"2012","journal-title":"Chem Sci"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib31","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1038\/s41467-023-41132-w","article-title":"Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation","volume":"14","author":"Jin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2026.104974_bib32","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","article-title":"The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection","volume":"9","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jpet.2026.104974_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jpet.2026.104974_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155135","article-title":"Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis","volume":"122","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104974_bib36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib37","first-page":"63","article-title":"Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer","volume":"8","author":"Zhou","year":"2021","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib38","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1038\/s41598-017-07609-7","article-title":"Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH","volume":"7","author":"Rao","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpet.2026.104974_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12967-020-02212-3","article-title":"Bevacizumab treatment of meningeal melanoma metastases","volume":"18","author":"Simonsen","year":"2020","journal-title":"J Transl Med"},{"issue":"9","key":"10.1016\/j.jpet.2026.104974_bib40","first-page":"1983","article-title":"Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470","volume":"56","author":"Devineni","year":"1996","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104974_bib41","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cellsig.2006.11.009","article-title":"Redox signalling in anchorage-dependent cell growth","volume":"19","author":"Chiarugi","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.jpet.2026.104974_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155945","article-title":"Saikosaponin D potentiates the antineoplastic effects of doxorubicin in drug-resistant breast cancer through perturbing NQO1-mediated intracellular redox balance","volume":"133","author":"Luo","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.jpet.2026.104974_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1532-0456(02)00117-5","article-title":"Characterization of HIF-1 alpha overexpressing HeLa cells and implications for gene therapy","volume":"133","author":"Hofer","year":"2002","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"7784","key":"10.1016\/j.jpet.2026.104974_bib44","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"Fritsch","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jpet.2026.104974_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.238","article-title":"Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.jpet.2026.104974_bib46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41418-019-0441-3","article-title":"Membrane-bound TNF mediates microtubule-targeting chemotherapeutics-induced cancer cytolysis via juxtacrine inter-cancer-cell death signaling","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.jpet.2026.104974_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","article-title":"Mitochondria and cell death-associated inflammation","volume":"30","author":"Vringer","year":"2023","journal-title":"Cell Death Differ"},{"issue":"8","key":"10.1016\/j.jpet.2026.104974_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jpet.2026.104974_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.actbio.2023.05.018","article-title":"Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy","volume":"166","author":"Liu","year":"2023","journal-title":"Acta Biomater"},{"issue":"18","key":"10.1016\/j.jpet.2026.104974_bib50","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.neuron.2024.07.026","article-title":"Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier","volume":"112","author":"Xie","year":"2024","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jpet.2026.104974_bib51","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) \u2013 key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom J Morphol Embryol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104974_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/ph18020180","article-title":"Diverse roles of antibodies in antibody-drug conjugates","volume":"18","author":"Yamaguchi","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.jpet.2026.104974_bib53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/neuonc\/nou147","article-title":"Targeting adaptive glioblastoma: an overview of proliferation and invasion","volume":"16","author":"Xie","year":"2014","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104974_bib54","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1093\/neuonc\/noaf099","article-title":"Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade","volume":"27","author":"Hung","year":"2025","journal-title":"Neuro Oncol"},{"issue":"28","key":"10.1016\/j.jpet.2026.104974_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:11:33Z","timestamp":1787926293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022356526011730"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104974","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel NAD(P)H:quinone oxidoreductase 1-responsive vascular endothelial growth factor-targeted antibody-drug conjugate induces dual apoptosis and ferroptosis in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104974"}}